South Dakota Investment Council Repligen Corp Transaction History

South Dakota Investment Council

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$140.68 - $188.02 $565,111 - $755,276	4,017 New	4,017 $652,000
Q4 2021 Feb 08, 2022	SELL	$247.59 - $304.47 $63,878 - $78,553	-258 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$194.77 - $324.21 $837,511 - $1.39 Million	-4,300 Reduced 94.34%	258 $75,000
Q2 2021 Aug 11, 2021	BUY	$165.87 - $220.95 $36,491 - $48,609	220 Added 5.07%	4,558 $910,000
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $6,854 - $8,597	38 Added 0.88%	4,338 $843,000
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $94,330 - $140,480	1,000 Added 30.3%	4,300 $532,000
Q3 2019 Nov 13, 2019	BUY	$76.65 - $95.51 $145,635 - $181,469	1,900 Added 135.71%	3,300 $253,000
Q1 2019 May 03, 2019	BUY	$49.45 - $62.8 $69,230 - $87,920	1,400 New	1,400 $83,000
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $528,840 - $666,361	-11,300 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$35.26 - $47.04 $1.67 Million - $2.23 Million	-47,400 Reduced 80.75%	11,300 $532,000
Q4 2017 Feb 09, 2018	SELL	$32.53 - $38.92 $87,831 - $105,084	-2,700 Reduced 4.4%	58,700 $2.13 Million
Q3 2017 Nov 09, 2017	BUY	$36.98 - $46.06 $2.27 Million - $2.83 Million	61,400	61,400 $2.35 Million

482

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.73B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.